Evaluation of serum adenosine deaminase activity with reference to dyslipidemia in ischemic heart disease

---

Original Article

Author Details : Pampa Reddy B Kollur, Raghunandana R , Girish M Desai, Netravati Sajjan, Sunilkumar Biradar*

Volume : 9, Issue : 2, Year : 2022

Article Page : 128-131

https://doi.org/10.18231/j.ijpo.2022.031

Suggest article by email

Get Permission

---

Abstract

Background: Ischemic health disease is a major health and a modern epidemic which is increasing in India. Dyslipidemia is a major risk factor for atherosclerosis. Serum adenosine deaminase activity is associated with coronary artery disease.
Aims and Objectives: The present work was done to understand the relation of serum adenosine deaminase activity with dyslipidemia in ischaemic heart disease.
Materials and Methods: This cross-sectional study comprised 200 subjects; healthy and myocardial infarction. Serum ADA and lipids were estimated. Obtained data was statistically analysed.
Result: Increase in serum ADA activity correlating with dyslipidemia was found in Myocardial infarction subjects.
Discussion: Increased ADA has role in LDL oxidation, dyslipidemia, foam cell transformation etc. leading to atherosclerosis and ischemic heart disease.
Conclusion: Adenosine deaminase has a crucial role in the evolution of ischemic heart disease through dyslipidemia and coronary artery disease.
 

Keywords: Adenosine deaminase, Ischemic heart disease, Atherosclerosis, Lipids

How to cite : Kollur P R B, Raghunandana R, Desai G M, Sajjan N, Biradar S, Evaluation of serum adenosine deaminase activity with reference to dyslipidemia in ischemic heart disease. Indian J Pathol Oncol 2022;9(2):128-131

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.